BioSpace News Archive

POXEL SA (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), today announced its cash position and revenue for the third quarter and nine months ended September 30, 2019.

One year since the Health Transformation Alliance (HTA) selected Welltok as its principal partner for consumer health activation, 20% of HTA members have made a greater commitment to employee total wellbeing.

OWC Pharmaceutical Research Corp. (OTCQB: OWCP), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, announced today that, on September 25, 2019, One World Cannabis Ltd., a company organized and existing under the laws of Israel and a wholly-owned subsidiary of OWC received Top Line Results

KALY has implemented a parallel business strategy to more immediately monetize its patented intellectual property through consumer applications of its technology.

TECLens, a medical device manufacturer and SERVImed Industrial Spa, an ophthalmic medical devices manufacturer and distributor today announced their partnership aimed at development and FDA approval of a new combination product to treat keratoconus.

SaVida Health, a leader in outpatient medication-assisted treatment for opioid and alcohol addiction, is opening a new treatment center in Colchester, VT on October 17th

Quantitative Systems Pharmacology (QSP) Day November 12, 2019 from 2-7p.m. at the AC Hotel by Marriott San Francisco Airport/Oyster Point Waterfront in South San Francisco, CA.

Apristor®, an oral progesterone receptor antagonist, is being studied in combination with an antiestrogen in advanced ER+,PR+,HER2- breast cancer

Currently, the minimum wage in Colorado is $11.10 per hour and the federal minimum wage is $7.25 per hour.

Illumina, Inc. (NASDAQ: ILMN) and QIAGEN N.V. (NYSE: QGEN) (Frankfurt Prime Standard: QIA) today announced a 15-year partnership intended to broaden the availability and use of NGS-based IVD kits, including companion diagnostics, for patient management.